Published in Crit Care on January 01, 2006
Recommendations for sepsis management in resource-limited settings. Intensive Care Med (2012) 2.03
High mixed venous oxygen saturation levels do not exclude fluid responsiveness in critically ill septic patients. Crit Care (2011) 0.90
Positive effect of septimeb™ on mortality rate in severe sepsis: a novel non antibiotic strategy. Daru (2012) 0.89
Contact-free monitoring of circulation and perfusion dynamics based on the analysis of thermal imagery. Biomed Opt Express (2014) 0.82
Development of a standard operating procedure and checklist for rapid sequence induction in the critically ill. Scand J Trauma Resusc Emerg Med (2014) 0.79
Pharmacological optimization of tissue perfusion. Br J Anaesth (2009) 0.78
Sepsis in pregnancy and early goal-directed therapy. Obstet Med (2009) 0.75
A System for Continuous Estimating and Monitoring Cardiac Output via Arterial Waveform Analysis. J Biomed Phys Eng (2017) 0.75
Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med (2001) 51.99
Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med (2001) 46.58
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med (2003) 28.68
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med (2004) 24.47
The pathophysiology and treatment of sepsis. N Engl J Med (2003) 21.67
A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med (1999) 20.31
A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med (2004) 12.79
Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med (1994) 7.05
Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. BMJ (1998) 6.80
Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest (1988) 6.29
Relation between respiratory changes in arterial pulse pressure and fluid responsiveness in septic patients with acute circulatory failure. Am J Respir Crit Care Med (2000) 5.53
Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med (1990) 5.15
Predicting fluid responsiveness in ICU patients: a critical analysis of the evidence. Chest (2002) 4.71
Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation (1997) 4.54
Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med (2004) 4.24
Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med (1984) 3.81
Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA (1993) 3.23
Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med (2001) 3.16
Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med (2000) 3.00
The pathogenesis of vasodilatory shock. N Engl J Med (2001) 2.94
Cardiovascular management of septic shock. Crit Care Med (2003) 2.72
Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med (1999) 2.67
Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology (2002) 2.59
High-dose vasopressin is not superior to norepinephrine in septic shock. Crit Care Med (2003) 2.43
Renal effects of norepinephrine in septic and nonseptic patients. Chest (2004) 2.37
Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Crit Care Med (1983) 2.36
Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med (2004) 2.33
Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest (1993) 2.24
Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? Crit Care Med (2003) 2.23
Circulating vasopressin levels in septic shock. Crit Care Med (2003) 2.22
Physiology of vasopressin relevant to management of septic shock. Chest (2001) 2.17
Effect of norepinephrine on the outcome of septic shock. Crit Care Med (2000) 1.95
Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med (2001) 1.82
Biologic effects of leukocytes present in transfused cellular blood products. Blood (1994) 1.65
Pathogenesis of sepsis: new concepts and implications for future treatment. BMJ (2003) 1.37
Colloid use for fluid resuscitation: evidence and spin. Ann Intern Med (2001) 1.34
The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA (1994) 1.30
Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma (1999) 1.13
Effects of norepinephrine on the renal vasculature in normal and endotoxemic dogs. Am J Respir Crit Care Med (1999) 1.03
Myocardial depression characterizes the fatal course of septic shock. Surgery (1992) 0.98
Management of severe sepsis and septic shock. Curr Opin Crit Care (2004) 0.93
The effects of low-dose dopamine on splanchnic blood flow and oxygen uptake in patients with septic shock. Intensive Care Med (1997) 0.93
Dobutamine administration in septic shock: addition to a standard protocol. Crit Care Med (1990) 0.91
The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock. Chest (2003) 0.88
The surviving sepsis guidelines: not another "groundhog day". Crit Care Med (2004) 0.81
Dopexamine hydrochloride in septic shock. Chest (1996) 0.79
Dobutamine: a hemodynamic evaluation in human septic shock. Crit Care Med (1981) 0.78
Use of dopexamine hydrochloride in patients with septic shock. Crit Care Med (1989) 0.76
Dobutamine in elderly septic shock patients refractory to dopamine. Intensive Care Med (1987) 0.76
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med (2004) 24.47
The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med (2010) 6.69
Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med (2014) 5.70
Translating research to clinical practice: a 1-year experience with implementing early goal-directed therapy for septic shock in the emergency department. Chest (2006) 5.31
The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med (2010) 4.64
Impact of delayed transfer of critically ill patients from the emergency department to the intensive care unit. Crit Care Med (2007) 4.54
Inhaled nitric oxide does not reduce mortality in patients with acute respiratory distress syndrome regardless of severity: systematic review and meta-analysis. Crit Care Med (2014) 4.11
Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis (2012) 4.07
Lactate measurements in sepsis-induced tissue hypoperfusion: results from the Surviving Sepsis Campaign database. Crit Care Med (2015) 3.55
Early microcirculatory perfusion derangements in patients with severe sepsis and septic shock: relationship to hemodynamics, oxygen transport, and survival. Ann Emerg Med (2006) 3.36
The next generation of sepsis clinical trial designs: what is next after the demise of recombinant human activated protein C?*. Crit Care Med (2014) 3.17
Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. JAMA (2004) 3.07
Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study. Crit Care Med (2015) 2.81
Critical care medicine training and certification for emergency physicians. Ann Emerg Med (2005) 2.67
Relationship between supranormal oxygen tension and outcome after resuscitation from cardiac arrest. Circulation (2011) 2.65
Multicenter study of early lactate clearance as a determinant of survival in patients with presumed sepsis. Shock (2009) 2.59
Point: Are the best patient outcomes achieved when ICU bundles are rigorously adhered to? Yes. Chest (2013) 2.59
An international survey: Public awareness and perception of sepsis. Crit Care Med (2009) 2.40
Activated protein C and septic shock: a propensity-matched cohort study*. Crit Care Med (2012) 2.39
Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis (2004) 2.17
Critical care medicine training and certification for emergency physicians. Crit Care Med (2005) 2.12
Transfusion of packed red blood cells is not associated with improved central venous oxygen saturation or organ function in patients with septic shock. J Emerg Med (2012) 2.02
Sepsis change bundles: converting guidelines into meaningful change in behavior and clinical outcome. Crit Care Med (2004) 1.96
Serum lactate as a predictor of mortality in patients with infection. Intensive Care Med (2007) 1.88
Interaction between fluids and vasoactive agents on mortality in septic shock: a multicenter, observational study. Crit Care Med (2014) 1.72
A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsis. Crit Care Med (2013) 1.58
Use of a standardized order set for achieving target temperature in the implementation of therapeutic hypothermia after cardiac arrest: a feasibility study. Acad Emerg Med (2008) 1.46
Sepsis severity score: an internationally derived scoring system from the surviving sepsis campaign database*. Crit Care Med (2014) 1.46
Randomized controlled trial of inhaled nitric oxide for the treatment of microcirculatory dysfunction in patients with sepsis*. Crit Care Med (2014) 1.42
Drotrecogin alfa (activated) in an infant with gram-negative septic shock. J Intensive Care Med (2004) 1.42
Inhaled nitric oxide: should it be used in acute respiratory distress syndrome? Crit Care Med (2006) 1.39
Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study. Intensive Care Med (2014) 1.38
Advances in pathogenesis and management of sepsis. Curr Opin Infect Dis (2007) 1.23
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Crit Care Med (2017) 1.15
Fluid resuscitation influences cardiovascular performance and mortality in a murine model of sepsis. Intensive Care Med (2008) 1.14
Infections and severe sepsis in solid-organ transplant patients admitted from a university-based ED. Am J Emerg Med (2004) 1.10
Reducing mortality in severe sepsis: the Surviving Sepsis Campaign. Clin Chest Med (2008) 1.01
Lactate as a hemodynamic marker in the critically ill. Curr Opin Crit Care (2012) 0.99
The Surviving Sepsis Campaign: a history and a perspective. Surg Infect (Larchmt) (2010) 0.97
Early arterial hypotension is common in the post-cardiac arrest syndrome and associated with increased in-hospital mortality. Resuscitation (2008) 0.96
The International Sepsis Forum's controversies in sepsis: my initial vasopressor agent in septic shock is norepinephrine rather than dopamine. Crit Care (2002) 0.92
Ventricular dilation is associated with improved cardiovascular performance and survival in sepsis. Chest (2010) 0.91
Targeting the lipopolysaccharides: still a matter of debate? Curr Opin Anaesthesiol (2008) 0.87
The impact of packed red blood cell transfusion on clinical outcomes in patients with septic shock treated with early goal directed therapy. Indian J Crit Care Med (2010) 0.87
Care of critically ill surgical patients using the 80-hour Accreditation Council of Graduate Medical Education work-week guidelines: a survey of current strategies. Am Surg (2006) 0.86
Systemic Inflammatory Response Syndrome Criteria for Severe Sepsis. N Engl J Med (2015) 0.86
Discordance between microcirculatory alterations and arterial pressure in patients with hemodynamic instability. J Crit Care (2012) 0.84
The Surviving Sepsis Campaign: 2013 and beyond. Chin Med J (Engl) (2013) 0.83
Porcine models of severe sepsis: emphasis on porcine peritonitis. Shock (2005) 0.83
Assessment of asymmetric lung disease in intensive care unit patients using vibration response imaging. Anesth Analg (2008) 0.83
Recent developments in the treatment of sepsis. Expert Opin Investig Drugs (2003) 0.82
Positive clinical impact of low tidal volume strategy. Crit Care Med (2005) 0.82
Treatment options for severe sepsis and septic shock. Expert Rev Anti Infect Ther (2006) 0.82
The International Sepsis Forum's frontiers in sepsis: High cardiac output should not be maintained in severe sepsis. Crit Care (2003) 0.82
Effectiveness of an inspiratory pressure-limited approach to mechanical ventilation in septic patients. Eur Respir J (2012) 0.81
Guidelines for severe infections: are they useful? Curr Opin Crit Care (2006) 0.81
Critical care medicine as a distinct product line with substantial financial profitability: the role of business planning. Crit Care Med (2004) 0.80
Steroid therapy of septic shock: the decision is in the eye of the beholder. Crit Care Med (2008) 0.79
Targeting endotoxin in the treatment of sepsis. Subcell Biochem (2010) 0.79
Case report: vibration response imaging findings following inadvertent esophageal intubation. Can J Anaesth (2008) 0.78
Shock overview. Semin Respir Crit Care Med (2004) 0.78
Other supportive therapies in sepsis: an evidence-based review. Crit Care Med (2004) 0.78
TAKEDA-143242 increased survival via reduced cytokines in porcine peritonitis. J Surg Res (2010) 0.77
Crystalloids for fluid resuscitation in sepsis: where is the balance? Ann Intern Med (2014) 0.77
A prospective multicenter cohort study of the association between global tissue hypoxia and coagulation abnormalities during early sepsis resuscitation. Crit Care Med (2010) 0.77
Talactoferrin in Severe Sepsis: Results From the Phase II/III Oral tAlactoferrin in Severe sepsIS Trial. Crit Care Med (2015) 0.77
Arterial pressure optimization in the treatment of septic shock: a complex puzzle. Crit Care (2010) 0.77
Current treatment of severe sepsis. Curr Infect Dis Rep (2006) 0.77
Continuous cardiac index monitoring: A prospective observational study of agreement between a pulmonary artery catheter and a calibrated minimally invasive technique. Resuscitation (2009) 0.77
2008 update of international guidelines for the management of severe sepsis and septic shock: should we change our current clinical practice? Pol Arch Med Wewn (2008) 0.76
Location of patients before transfer to a tertiary care intensive care unit: impact on outcome. J Crit Care (2008) 0.76
The authors reply. Crit Care Med (2013) 0.76
A new role for statins in sepsis. Crit Care (2013) 0.76
Ethics roundtable: Using new, expensive drugs. Crit Care (2002) 0.75
The association of prior statin use in septic shock treated with early goal directed therapy. Eur J Emerg Med (2012) 0.75
A rose is a rose is a rose? Crit Care Med (2012) 0.75
The authors reply. Crit Care Med (2013) 0.75
The authors reply. Crit Care Med (2013) 0.75
The authors reply. Crit Care Med (2013) 0.75
Severe sepsis in an emergency department: prevalence, rapid identification, and appropriate treatment. Crit Care Med (2007) 0.75
The authors reply. Crit Care Med (2013) 0.75
The authors reply. Crit Care Med (2013) 0.75
Contrasting treatment and outcomes of septic shock: presentation on hospital floors versus emergency department. Chin Med J (Engl) (2010) 0.75
The authors reply. Crit Care Med (2014) 0.75
Inhaled nitric oxide: another weapon in our armamentarium in the battle against acute hypoxic respiratory failure in preterm infants. Crit Care (2004) 0.75
Rebuttal from Drs Dellinger and Townsend. Chest (2013) 0.75
The authors reply. Crit Care Med (2015) 0.75
The authors reply. Crit Care Med (2013) 0.75
Endotoxin removal: how far from the evidence? From EUPHAS to EUPHRATES. Contrib Nephrol (2010) 0.75
Hemodynamic resuscitation in septic shock: cardiovascular support and adjunctive therapy. Curr Infect Dis Rep (2009) 0.75